Ciprofibrate-d<sub>6</sub>

Ciprofibrate-d6

CAT N°: 33917
Price:

From 163.00 138.55

Ciprofibrate-d6 is intended for use as an internal standard for the quantification of ciprofibrate (Item No. 18515) by GC- or LC-MS. Ciprofibrate is an agonist of peroxisome proliferator-activated receptor ? (PPAR?; EC50 = 0.9 µM in a transactivation assay).{61725} It is selective for PPAR? over PPAR? and PPAR? at 300 µM.{7009} Ciprofibrate (250 µM) induces cell cycle arrest at the G2/M and S phases in Fao rat, but not HepG2 human, hepatocellular carcinoma cells.{61726} It decreases fasting plasma levels of triglycerides and increases fasting plasma glucose levels in the apolipoprotein CIII transgenic mouse model of hypertriglyceridemia when administered at a dose of 10 mg/kg.{29848} Formulations containing ciprofibrate have been used in the treatment of hypertriglyceridemia.

We also advise you